GAN-CARD

Top Story

Medtronic’s new direct aortic approach to TAVI wins European approval

European regulators have approved the delivery of Medtronic‘s CoreValve System using a new direct aortic approach in patients with severe aortic stenosis. Transcatheter aortic valve implantation (TAVI) is a less-invasive alternative to open-heart surgery for aortic valve replacement, but some patients are unsuited for the procedure because they have small vessels. The newly CE Marked […]

Devices & Diagnostics

AtriCure stock plunges on FDA clinical trial concerns

Cardiac device maker AtriCure (NASDAQ:ATRC) saw its stock plunge Monday after an FDA report expressed “concerns” about a clinical trial for one of the company’s ablation devices. U.S. Food and Drug Administration staffers issued a (pdf) report in advance of an FDA advisory panel’s Wednesday meeting to review AtriCure’s application for approval of an atrial […]

Devices & Diagnostics

St. Jude expands cardiac imaging offerings in India

St. Jude Medical (NYSE:STJ) this week rolled out one of its heart imaging products in India: the C7-XR Optical Coherence Tomography (OCT) Intravascular Imaging System with the C7 Dragonfly Imaging Catheter. It’s a natural addition to the St. Jude product line in the country. The imaging system is used by interventional cardiologists to help with […]

Devices & Diagnostics

EXCMR readies clinical pilot of MRI-compatible heart-test treadmill

Ohio State University spinoff EXCMR is preparing for a fourth-quarter launch of a four-site clinical test of its MRI-compatible treadmill for heart-stress testing. The clinical test’s chief goal is to compare the performance of the company’s stress test against competing alternatives and fine-tune the treadmill’s design, plus its installation and servicing processes. “Launching this pilot […]

presented by
Devices & Diagnostics

AtriCure: FDA panel to review application for atrial fibrillation label

A U.S. Food and Drug Administration panel will review cardiac device maker AtriCure‘s (NASDAQ:ATRC) application for a label for the surgical treatment of atrial fibrillation. On Oct. 26, the FDA’s Circulatory System Devices Panel will review the Cincinnati-area device maker’s Premarket Approval Application (PMA) for its Synergy ablation system, according to a statement from West […]

Devices & Diagnostics

Heart test company CardiOx closes $8M series C round

Heart test-maker CardiOx has closed an $8 million series C round of investment that the company plans to use to begin U.S. and European commercialization. The round was led by Michigan-based Lifeline Ventures, a new investor in Columbus, Ohio-based CardiOx, and included contributions from existing investors Early Stage Partners, Glengary and Reservoir Partners, CardiOx CEO […]

Devices & Diagnostics

VasoStar’s vibrating guidewire takes aim at coronary artery blockages

A Cleveland-area startup is developing an electromagnetic vibrating catheter and guidewire system that could give interventional cardiologists a better means of pushing through serious coronary artery blockages called chronic total occlusions. Mentor, Ohio-based VasoStar recently received a $1 million grant through Ohio’s Third Frontier technology acceleration program that the company plans to use to fund […]